Pramlintide
A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 177
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo and Metreleptin | Obesity or overweight | n/r | n/r | n/r | n/r |
| Pramlintide Acetate and Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| Pramlintide Acetate and Metreleptin | Obesity or overweight | n/r | n/r | n/r | n/r |
| Lead-In Period | Obesity or overweight | n/r | n/r | n/r | n/r |